← Holdings
BIO-B

Bio-Rad Laboratories, Inc. Class A

2 managers · $48M total
Data: SEC EDGAR 13F · 2026Q3
Manager holders · last 5 qtrsⓘ
2
2025Q2 – 2026Q2 · -1 QoQ
Total position
$48M
Combined value across tracked managers
Net move this quarter
↓ Trimming
Weighted by holders' share change
HolderQ actionValue% of port.Style
HoskingⓘAdd+1.1%$36M1.28%Contrarian value / Global diversified
MarathonTrim-21.78%$12M0.5%Capital cycle / Contrarian value
Earnings Callsⓘ

No earnings call data yet

FinancialsⓘFY2025 · Source: SEC EDGAR 10-K

5y revenue CAGR -3% · latest net margin 29.4% · FCF consistently positive

Revenue$2.58B
Rev. YoY+0.7%
Gross margin51.9%
Net margin29.4%
Net income$0.76B
Free cash flow$0.37B
Operating cash flow$0.53B
ROE10.2%

Source: SEC EDGAR company filings (10-K). Foreign issuers (20-F/IFRS) not yet covered.